1. Home
  2. HUMA

HUMA

Humacyte Inc.

Logo Humacyte Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 2:32pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Founded: 2004 Country:
United States
United States
Employees: N/A City: DURHAM
Market Cap: 369.2M IPO Year: N/A
Target Price: $7.00 AVG Volume (30 days): 1.1M
Analyst Decision: Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.07 EPS Growth: N/A
52 Week Low/High: $1.96 - $5.60 Next Earning Date: 05-10-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 980.83%

Share on Social Networks: